论文部分内容阅读
1984年3月,在旧金山召开了每三年一届的国际病毒性肝炎专题讨论会。会议对肝炎病毒的分子生物学和肝脏疾病的实验室诊断、流行病学、发病机理、预防及治疗都作了最新评价。本次会议的组织者和项目主持人是旧金山加利福尼亚大学的G N Vyas医师,与会代表约900名。会议报告的主要进展是关于乙型肝炎病毒(HBV)与肝细胞肝癌(HCC)的关系以及乙型肝炎疫苗的效能问题。显然,有关慢性病毒性肝炎的治疗和非甲非乙型肝炎的预防是有待进一步探索的领域。
In March 1984, the triennial International Symposium on Viral Hepatitis was held in San Francisco. The conference reviewed the laboratory diagnostics, epidemiology, pathogenesis, prevention and treatment of hepatitis B virus molecular biology and liver diseases. The conference organizer and project host is Dr. G N Vyas at the University of California, San Francisco, with about 900 participants. The main progress of the meeting report on the relationship between hepatitis B virus (HBV) and hepatocellular carcinoma (HCC) and the efficacy of hepatitis B vaccine. Obviously, the treatment of chronic viral hepatitis and the prevention of non-A, non-B hepatitis are areas to be further explored.